Search Results for "peginterferon alfa-2b"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for peginterferon alfa-2b. Results 1 to 5 of 5 total matches.
Peginterferon Alfa-2b (Sylatron) for Melanoma
The Medical Letter on Drugs and Therapeutics • Sep 19, 2011 (Issue 1373)
Peginterferon Alfa-2b (Sylatron) for Melanoma ...
The FDA has approved peginterferon alfa-2b (Sylatron – Merck) for adjuvant treatment of node-positive melanoma after surgical resection. Pegylated interferon has a longer duration of action than interferon alfa-2b (Intron A), which is also FDA-approved for adjuvant treatment of malignant melanoma after surgery, and can be given once a week, compared to 3-5 times a week for standard interferon.
Peginterferon Alfa-2a (Pegasys) for Chronic Hepatitis C
The Medical Letter on Drugs and Therapeutics • Mar 03, 2003 (Issue 1151)
with hepatitis C has been once-weekly injections of peginterferon alfa-2b (PEG-Intron − Schering) plus oral ...
The FDA has approved recombinant interferon alfa-2a conjugated to polyethylene glycol (Pegasys - Roche) alone or with oral ribavirin (Copegus - Roche) for treatment of adults with chronic hepatitis C virus (HCV) infections not previously treated with interferon alpha. The standard of care for treatment of most patients with hepatitis C has been once-weekly injections of peginterferon alfa-2b (PEG-Intron -Schering) plus oral ribavirin (Rebetol - Schering) (Medical Letter 2001; 43:54).
Telaprevir (Incivek) and Boceprevir (Victrelis) for Chronic Hepatitis C
The Medical Letter on Drugs and Therapeutics • Jul 25, 2011 (Issue 1369)
.
STANDARD THERAPY — Peginterferon alfa-2a
(Pegasys) or peginterferon alfa-2b (PegIntron) plus oral ...
Telaprevir (Incivek – Vertex) and boceprevir (Victrelis –
Merck) have been approved by the FDA for oral use in
combination with peginterferon and ribavirin for treatment
of chronic hepatitis C virus (HCV) genotype 1
infection in adults with compensated liver disease.
Both telaprevir and boceprevir were developed specifically
to inhibit the NS3/4A proteases that cleave HCV
encoded polyproteins of the genotype 1 virus.
Antiviral Drugs
Treatment Guidelines from The Medical Letter • Mar 01, 2013 (Issue 127)
patients.45,46
Peginterferon alfa-2b (PegIntron) may also be effective
in treating chronic hepatitis B47 ...
The drugs of choice for treatment of viral infections
(other than HIV) and their dosages are listed in Tables
1-6 on the pages that follow. Some of the indications
and dosages recommended here have not been
approved by the FDA. Vaccines used for the prevention
of viral infections are discussed elsewhere.
Simeprevir (Olysio) for Chronic Hepatitis C
The Medical Letter on Drugs and Therapeutics • Jan 06, 2014 (Issue 1433)
in combination with peginterferon alfa and ribavirin.
Peginterferon and ribavirin should be given ...
The FDA has recently approved 2 new drugs for treatment of chronic hepatitis C virus (HCV) infection. Simeprevir (Olysio – Janssen) is the third oral protease inhibitor to be approved for use in combination with peginterferon and ribavirin for treatment of chronic HCV genotype 1 infection in adults with compensated liver disease. Telaprevir (Incivek) and boceprevir (Victrelis) were approved in 2011 for the same indication. Sofosbuvir (Sovaldi – Gilead), a nucleotide analog polymerase inhibitor that has been approved for use with and without interferon for treatment of multiple HCV...